Lucid Diagnostics (NASDAQ: LUCD) Navigates Q1 2026: Revenue Growth, Price Target Adjustments, and Cash Runway
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameLucid Diagnostics Inc
-
Registration countryUSA
-
IndustryMedical Devices
-
М/S&P/F
*** /*** /***









